LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.61%1.37B | 7.33%1.33B | 8.12%1.28B | 13.28%5.14B | 47.35%1.42B | 6.72%1.3B | 3.14%1.24B | 2.33%1.18B | 7.41%4.54B | 13.46%963.26M |
Operating revenue | 5.61%1.37B | 7.33%1.33B | 8.12%1.28B | 13.28%5.14B | 47.35%1.42B | 6.72%1.3B | 3.14%1.24B | 2.33%1.18B | 7.41%4.54B | 13.46%963.26M |
Cost of revenue | 3.06%760.24M | 8.40%750.12M | 8.05%707.07M | 14.28%2.92B | 50.94%836.49M | 6.22%737.7M | 3.56%691.98M | 2.46%654.38M | 9.19%2.56B | 34.91%554.17M |
Gross profit | 8.98%610.33M | 5.96%578.79M | 8.21%572.43M | 11.99%2.22B | 42.49%582.9M | 7.39%560.03M | 2.61%546.23M | 2.16%529M | 5.19%1.98B | -6.66%409.1M |
Operating expense | 8.77%362.81M | 0.46%356.33M | 9.05%361.2M | 14.03%1.36B | 122.89%336.53M | 0.88%333.55M | 1.89%354.7M | -7.83%331.22M | -15.37%1.19B | -48.68%150.99M |
Selling and administrative expenses | 8.81%335.45M | 0.26%329.3M | 9.49%335.63M | 14.82%1.25B | 142.02%309.06M | 1.03%308.3M | 1.62%328.43M | -8.40%306.53M | -17.28%1.09B | -52.59%127.7M |
Research and development costs | 8.33%27.36M | 2.90%27.03M | 3.56%25.57M | 5.28%103.68M | 17.94%27.46M | -1.02%25.26M | 5.38%26.27M | -0.23%24.69M | 13.63%98.48M | -6.17%23.28M |
Operating profit | 9.29%247.52M | 16.15%222.46M | 6.80%211.23M | 8.92%862.16M | -4.55%246.38M | 18.67%226.48M | 3.97%191.53M | 24.84%197.78M | 65.65%791.59M | 79.14%258.11M |
Net non-operating interest income expense | 54.81%-16.66M | 48.06%-18.54M | 6.15%-29.08M | -20.28%-133.31M | 1.72%-29.76M | -21.02%-36.87M | -33.98%-35.7M | -32.14%-30.98M | -33.21%-110.84M | -49.22%-30.28M |
Non-operating interest income | 17.02%2.43M | -8.97%1.13M | -4.94%1.31M | --11.04M | --6.35M | --2.08M | --1.24M | --1.38M | ---- | ---- |
Non-operating interest expense | -50.98%19.09M | -46.75%19.67M | -6.10%30.38M | 30.24%144.35M | 19.25%36.11M | 27.85%38.95M | 38.62%36.94M | 38.02%32.36M | 23.85%110.84M | 39.73%30.28M |
Other net income (expense) | -35,216.67%-2.12M | -39,352.17%-9.03M | -36,200.00%-6.9M | -5,270.10%-26.05M | -105.31%-26.04M | 84.62%-6K | 100.00%23K | 26.92%-19K | 98.26%-485K | 1,581,412.90%490.21M |
Special income (charges) | -35,216.67%-2.12M | -39,352.17%-9.03M | -36,200.00%-6.9M | -5,270.10%-26.05M | -105.31%-26.04M | 84.62%-6K | 100.00%23K | 26.92%-19K | -910.42%-485K | 1,581,412.90%490.21M |
-Less:Restructuring and merger&acquisition | 37,083.33%2.23M | 12,256.52%2.8M | 135,163.16%25.7M | 5,270.10%26.05M | 7,174.58%26.04M | -84.62%6K | -137.10%-23K | -26.92%19K | 910.42%485K | 1,054.84%358K |
-Gain on sale of business | --112K | ---6.23M | --18.8M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Income before tax | 20.64%228.75M | 25.05%194.89M | 5.08%175.26M | 3.31%702.81M | -73.46%190.58M | 18.25%189.6M | 146.79%155.85M | 23.59%166.78M | 85.46%680.27M | 480.17%718.04M |
Income tax | 35.09%55.38M | 24.11%43.51M | -2.46%35.31M | 20.52%149.53M | -53.80%37.28M | 10.77%41M | 296.60%35.06M | 49.61%36.2M | 50.67%124.07M | 167.88%80.69M |
Net income | 22.95%173.29M | 29.93%151.17M | 17.57%145.54M | 259.20%380.08M | -100.54%-1M | 14.29%140.95M | 136.91%116.35M | 11.77%123.79M | -56.43%105.81M | 259.18%186.96M |
Net income continuous Operations | 16.66%173.36M | 25.32%151.39M | 7.17%139.95M | -0.52%553.28M | -75.95%153.3M | 20.50%148.6M | 138.32%120.8M | 17.90%130.58M | 95.53%556.2M | 580.62%637.35M |
Net income discontinuous operations | 99.01%-76K | 95.21%-213K | 182.34%5.59M | 61.54%-173.2M | ---154.3M | ---7.66M | ---4.45M | ---6.79M | -982.94%-450.38M | ---- |
Minority interest income | -223.27%-249K | 10.91%1.14M | -40.68%140K | 251.19%1.84M | 243.68%375K | 140.16%202K | 1,801.85%1.03M | 146.55%236K | -19.55%-1.22M | -25.48%-261K |
Net income attributable to the parent company | 23.30%173.53M | 30.10%150.03M | 17.68%145.4M | 253.40%378.24M | -100.74%-1.38M | 13.66%140.74M | 136.58%115.32M | 11.05%123.55M | -56.12%107.03M | 258.25%187.23M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 23.30%173.53M | 30.10%150.03M | 17.68%145.4M | 253.40%378.24M | -100.74%-1.38M | 13.66%140.74M | 136.58%115.32M | 11.05%123.55M | -56.12%107.03M | 258.25%187.23M |
Basic earnings per share | 23.24%1.75 | 29.91%1.52 | 16.80%1.46 | 257.94%3.83 | -100.53%-0.01 | 14.52%1.42 | 137.14%1.17 | 12.61%1.25 | -57.20%1.07 | 263.46%1.89 |
Diluted earnings per share | 23.24%1.75 | 30.17%1.51 | 16.80%1.46 | 256.07%3.81 | -100.53%-0.01 | 14.52%1.42 | 136.83%1.16 | 13.64%1.25 | -56.85%1.07 | 261.54%1.88 |
Dividend per share | 9.62%0.57 | 9.62%0.57 | 10.64%0.52 | 10.33%2.03 | 10.64%0.52 | 10.64%0.52 | 10.64%0.52 | 9.30%0.47 | 8.88%1.84 | 9.30%0.47 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |